A simulation from Wegovys manufacturer, Novo Nordisk, for example, found a savings of $85 million over five years for 100,000 patientsbut the current list price of Wegovy over that same period would run $8 billion, a huge discrepancy even if insurers do not pay full price
However, in contrast to anti-hyperlycemic agents such as metformin, pioglitazone and peroxisome proliferator-activated receptor gamma (PPAR) agonists, which were particularly well studied in this matter, very few clinical studies concerning the effects of GLP-1R targeting therapeutics on alleviation of depressive symptoms in humans have been carried out so far [118, 119]
For the average person, losing a bit of muscle isnt a major concern as long as theyre losing fat
17 GaberA.OgataT.MarutaT.YoshimuraK.TamoiM.ShigeokaS
Tested Sample Types: serum, plasma, animal tissue and cell